Was kaufen? Eurotech oder Swissray oder gar nix? - 500 Beiträge pro Seite
eröffnet am 25.08.02 19:20:28 von
neuester Beitrag 27.08.02 00:20:26 von
neuester Beitrag 27.08.02 00:20:26 von
Beiträge: 7
ID: 624.342
ID: 624.342
Aufrufe heute: 0
Gesamt: 243
Gesamt: 243
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
20.04.24, 12:11 | 225 | |
gestern 12:15 | 207 | |
gestern 23:15 | 172 | |
gestern 23:07 | 143 | |
06.03.17, 11:10 | 142 | |
heute 01:20 | 127 | |
heute 01:27 | 99 | |
gestern 22:28 | 81 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 1. | 18.015,00 | -0,90 | 204 | |||
2. | 2. | 9,6900 | -33,06 | 190 | |||
3. | 3. | 162,13 | +12,06 | 146 | |||
4. | 4. | 0,1940 | +1,57 | 69 | |||
5. | 5. | 6,7090 | -2,94 | 32 | |||
6. | 6. | 0,0211 | -32,59 | 29 | |||
7. | 7. | 1,3500 | -0,74 | 29 | |||
8. | 8. | 56,40 | +1,26 | 26 |
FAIRFAX, Va.--(BUSINESS WIRE)--Aug. 23, 2002--Eurotech, Ltd. (AMEX:EUO - News), www.eurotechltd.com, announced today that it has entered into a non-binding letter of intent with Hillcrest Avenue LLC ("Hillcrest") to acquire Hillcrest`s majority controlling interest in Swissray International, Inc. (OTC Bulletin Board: SRMI.OB- News), www.Swissray.com ("Swissray"), in an all stock transaction. Swissray is engaged in the design, manufacturing and marketing of proprietary direct digital Radiography (ddR) technology. This technology is utilized by the medical imaging marketplace to provide high quality digital radiographic images in seconds and at a lower cost than conventional radiography.
The terms of the letter of intent contemplate payment to Hillcrest in the range of $40 to $60 million stated value in the form of a new series of Eurotech 3% pay-in-kind ("PIK"), Five-Year Cumulative Convertible Preferred Stock. While terms of the Convertible Preferred Stock, including the principal amount, definitive stated value and redemption terms, remain to be finalized pending due diligence review, it is anticipated that the Convertible Preferred Stock will not be convertible into shares of common stock without the consent of Eurotech until two years after issuance and that the conversion rate will be related to the market price of Eurotech common stock at the time of conversion.
Swissray, located in Elmsford, New York, and Lucerne, Switzerland, is a worldwide leader in the market for direct digital radiography diagnostic imaging devices for the health care industry. These diagnostic imaging devices include X-ray equipment, computer tomography (CT) systems and magnetic resonance imaging (MRI) systems for three-dimensional projections, nuclear medicine (NM) imaging devices and ultrasound devices. Swissray manufactures and sells diagnostic X-ray equipment for all radiological applications other than mammography and dentistry. In addition, Swissray sells imaging systems and components and accessories for X-ray equipment manufactured by third parties and provides services related to diagnostic imaging. Swissray`s annual gross revenues exceed $20 million.
Any acquisition by Eurotech of the controlling interest in Swissray will require approval by Eurotech`s shareholders, as well as the approval of an additional listing application by the American Stock Exchange. Any such acquisition will also require that Eurotech procure adequate working capital for Swissray and is subject to completion of due diligence. Following the acquisition, Eurotech anticipates that it will restructure its corporate assets and management organization in order to gain further corporate management efficiency and reduce operating costs. Hillcrest and Woodward LLC, a major investor in Eurotech, may be deemed to be "affiliates" of each other within the meaning of the Securities Act of 1933, the Securities Exchange Act of 1934 and the rules thereunder.
Eurotech`s Vice Chairman Chad A. Verdi stated, "An acquisition of the majority controlling interest in Swissray, along with the financial restructuring currently being negotiated with Woodward LLC, is intended to improve the financial future for both the corporation and our shareholders. This transaction, if completed, along with reductions in operating cost structure, is designed to leave us with a healthy business going forward."
With respect to the corporate asset and management restructuring of Eurotech that has taken place to date, Chad A Verdi stated "Much good work has been accomplished to date by our dedicated team of employees, consultants, and directors. Even so, much more hard work lies ahead of us. We anticipate additional changes that will increase the visibility to our independent directors and we also appreciate the continued support and confidence of Woodward LLC."
In light of the resignation of Todd J. Broms on August 21st, as President and Chief Executive Officer, Chairman Don Hahnfeldt reassumed these duties of Eurotech, Ltd. on an interim basis to facilitate the corporate restructuring process until completion. Mr. Broms` resignation stated that he was resigning for "personal reasons."
morchel
The terms of the letter of intent contemplate payment to Hillcrest in the range of $40 to $60 million stated value in the form of a new series of Eurotech 3% pay-in-kind ("PIK"), Five-Year Cumulative Convertible Preferred Stock. While terms of the Convertible Preferred Stock, including the principal amount, definitive stated value and redemption terms, remain to be finalized pending due diligence review, it is anticipated that the Convertible Preferred Stock will not be convertible into shares of common stock without the consent of Eurotech until two years after issuance and that the conversion rate will be related to the market price of Eurotech common stock at the time of conversion.
Swissray, located in Elmsford, New York, and Lucerne, Switzerland, is a worldwide leader in the market for direct digital radiography diagnostic imaging devices for the health care industry. These diagnostic imaging devices include X-ray equipment, computer tomography (CT) systems and magnetic resonance imaging (MRI) systems for three-dimensional projections, nuclear medicine (NM) imaging devices and ultrasound devices. Swissray manufactures and sells diagnostic X-ray equipment for all radiological applications other than mammography and dentistry. In addition, Swissray sells imaging systems and components and accessories for X-ray equipment manufactured by third parties and provides services related to diagnostic imaging. Swissray`s annual gross revenues exceed $20 million.
Any acquisition by Eurotech of the controlling interest in Swissray will require approval by Eurotech`s shareholders, as well as the approval of an additional listing application by the American Stock Exchange. Any such acquisition will also require that Eurotech procure adequate working capital for Swissray and is subject to completion of due diligence. Following the acquisition, Eurotech anticipates that it will restructure its corporate assets and management organization in order to gain further corporate management efficiency and reduce operating costs. Hillcrest and Woodward LLC, a major investor in Eurotech, may be deemed to be "affiliates" of each other within the meaning of the Securities Act of 1933, the Securities Exchange Act of 1934 and the rules thereunder.
Eurotech`s Vice Chairman Chad A. Verdi stated, "An acquisition of the majority controlling interest in Swissray, along with the financial restructuring currently being negotiated with Woodward LLC, is intended to improve the financial future for both the corporation and our shareholders. This transaction, if completed, along with reductions in operating cost structure, is designed to leave us with a healthy business going forward."
With respect to the corporate asset and management restructuring of Eurotech that has taken place to date, Chad A Verdi stated "Much good work has been accomplished to date by our dedicated team of employees, consultants, and directors. Even so, much more hard work lies ahead of us. We anticipate additional changes that will increase the visibility to our independent directors and we also appreciate the continued support and confidence of Woodward LLC."
In light of the resignation of Todd J. Broms on August 21st, as President and Chief Executive Officer, Chairman Don Hahnfeldt reassumed these duties of Eurotech, Ltd. on an interim basis to facilitate the corporate restructuring process until completion. Mr. Broms` resignation stated that he was resigning for "personal reasons."
morchel
Jo morchel, natürlich Eurotech
wo liegt dein kursziel für EUO
wo liegt dein kursziel für EUO
heute über 1,5mio gehandelt letzten 3handelstage über 2,5mio
da wird morgen die post abgehn - was meinst du morchelchen??
da wird morgen die post abgehn - was meinst du morchelchen??
Ich komm zwar nicht ganz mit bei dem deal, aber EUO scheint die besseren Karten zu haben!
morgen 0,15 für EUO möglich
morchel
morgen 0,15 für EUO möglich
morchel
warum denn so zaghaft wenn eurotech abgeht dann richtig morchel!
bin etwas zaghaft, da bei EUO heute schon viele shares den Besitzer gewechselt haben und der Kursanstieg relativ gering war. Aber an der AMEX gehts eben nicht so fix!
morchel
morchel
du sagst es morchel AMEX geht es nicht so schnell wohlmöglich das es sogar morgen noch auf 0,11 fällt aber es wird abgehn!!!
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
204 | ||
190 | ||
146 | ||
69 | ||
32 | ||
29 | ||
29 | ||
26 | ||
26 | ||
25 |
Wertpapier | Beiträge | |
---|---|---|
24 | ||
23 | ||
23 | ||
23 | ||
22 | ||
22 | ||
22 | ||
21 | ||
20 | ||
20 |